Juan Carlos Hernández‐Boluda

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 363 citations · Full text

Hematological Malignancy, Ph Chromosome-positive Leukemia, Genetics +7

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

Alberto Álvarez‐Larrán, Francisco Cervantes, Arturo Pereira et al. · Blood · 2010 · 229 citations · Full text

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes et al. · Blood · 2011 · 221 citations · Full text

Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients

Carlos Besses, Francisco Cervantes, Arturo Pereira et al. · Leukemia · 1999 · 212 citations

Thrombopoiesis, Thrombosis, Venous Disease +14

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

Norma C. Gutiérrez, M. Castellanos, María Luisa Martín et al. · Leukemia · 2006 · 186 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12